Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (75 of 100 Patients Treated)
Expected to complete enrollment at the end of 2024
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

Theralase Technologies Inc. > Posting for a new COO and Clinical Trial Coordinator
View:
Post by z_investor on Aug 04, 2021 12:24pm

Posting for a new COO and Clinical Trial Coordinator

Just saw this on Indeed.

Clinical Study Coordinator
Theralase Technologies Inc. - Toronto, ON
$75,000 a year
The Anti-Cancer Therapy (“*ACT*”) division, which is a clinical stage, pre-commercialization research and development division dedicated to the research and…
Easily apply
3-Aug
Chief Operating Officer (COO)
Theralase Technologies Inc. - Toronto, ON
$250,000 a year
The Anti-Cancer Therapy (“*ACT*”) division, which is a clinical stage, pre-commercialization research and development division dedicated to the research and…
Easily apply
3-Aug
Comment by tamarindo1 on Aug 04, 2021 12:48pm
Chief Operating Officer appears to be for the Cool Laser Therapy Div. Both positions  have advertised starting time as 21-09-07
Comment by tamarindo1 on Aug 04, 2021 12:55pm
Starting comp. for COO up to $250,000, nice chunk of change, Same as CEO;s  2020 compensation.
Comment by tamarindo1 on Aug 04, 2021 12:59pm
These positions were listed on "Indeed" yesterday and today,  Somethin goin on?
Comment by Pandora on Aug 04, 2021 1:11pm
"Chief Operating Officer (COO) Theralase Technologies Inc. - Toronto, ON $250,000 a year The Anti-Cancer Therapy (“*ACT*”) division, which is a clinical stage, pre-commercialization research and development division dedicated to the research and…" When it says it is for the Anti-Cancer Therapy Division how does that sound like it is ...more  
Comment by Jaro1977 on Aug 04, 2021 1:21pm
when you click on the description on Indeed it does say for the Cool Laser Therapy Division Description: The successful candidate for the Chief Operating Officer – Cool Laser Therapy Division (“COO”) position will have 10+ years of hands-on operational experience in the triple digit revenue growth of a medical device division, through the leadership and hands-on management of ...more  
Comment by tamarindo1 on Aug 04, 2021 1:24pm
Chief Operating Officer (COO) Theralase Technologies Inc. - Toronto, ON $250,000 a year - Full-time, Temporary, Contract Apply Now     Chief Operating Officer – Cool Laser Therapy Division Overview: Theralase® Technologies Inc. (“Theralase®”) is a publicly traded ...more  
Comment by Pandora on Aug 04, 2021 4:59pm
OK, thanks.
Comment by Eoganacht on Aug 04, 2021 6:54pm
That's very interesting. The ad for the Chief Operating Officer – Cool Laser Therapy Division says: "The COO will be responsible for:   1) Primary – Triple digit revenue growth of the Company’s current medical devices. 2) Secondary – Research, development, regulatory approval and successful launch of the Company’s new medical devices   The COO will ...more  
Comment by StevenBirch on Aug 04, 2021 7:30pm
That also caught my eye, thanks Eog. Not only do I not take the daily trading hijinks or rumours seriously, unless abnormal volume, and will read the update from the company when we finally get it but I will wait for analysis from Eog, Enrique et al for real clarity.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 75 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 72 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250